Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Gastroenterology-GI drug development clinical trial support - Medpace gastroenterology - GI CRO
Gastroenterology Clinical Research

Learn More

Gastroenterology CRO for Clinical Research

With extensive global expertise in the design and medical oversight of gastroenterology clinical trials, Medpace is well-positioned to help our clients develop new and effective treatments for digestive disorders and diseases. Medpace is the gastroenterology CRO that helps our clients:

  • Optimize clinical trial design
  • Proactively assess and meet potential regulatory challenges
  • Standardize patient inclusion and efficacy outcome assessment

Gastroenterology Experience

Experience in all major gastroenterology indications, spanning both adult and pediatric populations.
  • Inflammatory Bowel Disease including:
    • Ulcerative Colitis
    • Crohn's Disease
  • Functional GI Disorders including:
    • Chronic Idiopathic Constipation (also drug-induced constipation)
    • Irritable Bowel Syndrome
    • Postprandial Distress and Gastroparesis (also GERD)
  • Liver Disease including:
    • Viral Hepatitis
    • Nonalcoholic steatohepatitis (NASH)

The Medpace Difference for Gastroenterology Studies

In addition to the Medpace Difference that applies to all of our therapeutic areas, our gastroenterology clients benefit from:

  • Gastroenterology medical expert with a background in both hospital-based clinical practice and pharmaceutical development.
    • Recognized in the field for his contribution to the pioneering work on standardization of central imaging in inflammatory bowel disease drug development.
    • Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom.
  • Centralized imaging services for efficient, cost-effective assessment of efficacy outcomes.
  • Global central laboratories that can help design and execute your protocol testing needs with a strong selection of inflammatory biomarkers and cytokines.